Navigation Links
Tengion Announces Pricing of $31.4 Million Private Placement
Date:3/1/2011

signed to delay or prevent the need for dialysis or transplantation in patients at risk for kidney failure. Tengion has also applied its technology in two Phase II clinical trials for Tengion's Neo-Bladder Augment™ for the treatment of neurogenic bladder. Tengion has worldwide rights to its product candidates. For more information, please visit www.tengion.com.

Forward-Looking Statements

Any statements contained in this press release that refer to future events or other non-historical matters are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These include statements relating to whether and when the private placement will close and Tengion's anticipated uses of the net proceeds of the transaction. These forward-looking statements are based on Tengion's expectations as of the date of this press release and are subject to certain risks and uncertainties that could cause actual results to differ materially as set forth in the Company's public filings with the Securities and Exchange Commission, including Tengion's Quarterly Report on Form 10-Q for the quarter ended September 30, 2010. Tengion disclaims any intent or obligation to update any forward-looking statements, whether because of new information, future events or otherwise, except as required by applicable law.


'/>"/>
SOURCE Tengion
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Tengion Addresses Recent Trading Activity in its Common Stock
2. Tengion to Present at the 13th Annual BIO CEO & Investor Conference and the Leerink Swann Hot Topics in Therapeutics Roundtable Conference
3. Tengion Presents New Large Animal Data Demonstrating Functional Kidney Regeneration at the American Society for Transplantation Annual Conference
4. Tengion Appoints Richard E. Kuntz, MD to its Board of Directors
5. Tengion Announces Webcast of Analyst and Investor Meeting on October 27, 2010
6. Tengion Appoints A. Brian Davis Chief Financial Officer
7. Tengion Presents New Data Supporting its Organ Regeneration Platform™ at 8th Annual Meeting of the International Society for Stem Cell Research
8. Tengion Presents New Data Supporting Key Urologic and Kidney Programs at 16th Annual Meeting of the International Society for Cellular Therapy
9. Tengion to Present at the Piper Jaffray 20th Annual Healthcare Conference
10. Tengion Announces Second Closing of Series C Financing
11. Tengion Featured as Model of Innovation and Success at 35th Anniversary Celebration of the National Venture Capital Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Feb. 26, 2015 S&P Capital IQ (MHFI) ... Report coverage on MabVax Therapeutics Holdings Inc . ... clinical stage biotechnology company focused on the development of ... in the treatment of cancer. MabVax has discovered a ... protective immune responses generated by patients who have been ...
(Date:2/26/2015)... On behalf of biotech client GenScript ... Goldman & Spitzer, P.A. (Wilentz) secured a significant jury ... in excess of $10 million. The jury determined that ... that it improperly hired one or more of GenScript,s ... judgment notwithstanding the verdict, a new trial, and remittitur. ...
(Date:2/26/2015)... , Feb. 26, 2015  23andMe, the leading ... Kate Black as Privacy Officer and Corporate Counsel. ... state privacy laws as well as health care regulations. ... she will be responsible for reviewing, updating and enhancing ... the U.S. and abroad. She joined the company January ...
(Date:2/26/2015)... , Feb. 26, 2015 /PRNewswire/ - SQI Diagnostics ... a life sciences company that develops and commercializes proprietary ... its financial and operational results for the fiscal first ... press release are in Canadian dollars (CAD), unless otherwise ... continued to win new business from our existing customers ...
Breaking Biology Technology:S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 323andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6
... Study Recruiting Adult Parkinson,s Patients with Behavioral Changes ... 22 Parkinson,s disease affects 6.3 million people worldwide. ... on movement such as tremors, less known is that ... that include hallucinations, illusions and delusions. ACADIA Pharmaceuticals, a ...
... Company,s groundbreaking products are featured in Genetic Engineering News for delivering ... ... Fort Collins, CO (PRWEB) January 22, 2009 -- InVitria,s ... Genetic Engineering News (GEN, Jan 15, 2009 pp 32-34). The article, ...
... company Lytix Biopharma today announced the closure of a,successful ... NOK (US$ 10.4,million), the proceeds of which will fund ... Lytix develops novel lytic peptide drugs ... well as first-in-class oncology,treatments - both areas with high ...
Cached Biology Technology:Clinical Research Study Focuses on Little Known Behavioral Changes Related to Parkinson's Disease 2InVitria Among Leading Innovators in Cell Culture Media According to Top Biotechnology Publication 2Lytix Closes USD 10.4 Million Funding Round 2
(Date:2/25/2015)... 25, 2015  ABC Financial Services (ABC), the ... Health and Fitness Industry, today announced enhancements to ... The latest upgrade includes advances to the agreement ... check-in via Identity One fingerprint biometrics. The features ... interactive displays at the International Health, Racquet & ...
(Date:2/24/2015)... This report analyzes the worldwide markets for Iris Biometrics in ... US, Canada , Japan ... , Middle East , and ... for the period 2013 through 2020. Also, a seven-year historic ... are derived from primary and secondary research. Company profiles are ...
(Date:2/24/2015)... report analyzes the worldwide markets for Face and Voice Biometrics in ... The report provides separate comprehensive analytics for the US, ... , Asia-Pacific , Middle East ... Latin America . Annual estimates and forecasts are provided for ... provided for these markets. Market data and analytics are derived from ...
Breaking Biology News(10 mins):ABC Financial Unveils New Software Enhancements 2ABC Financial Unveils New Software Enhancements 3World Iris Biometrics Industry 2World Iris Biometrics Industry 3World Iris Biometrics Industry 4World Iris Biometrics Industry 5World Iris Biometrics Industry 6World Iris Biometrics Industry 7World Iris Biometrics Industry 8World Iris Biometrics Industry 9World Iris Biometrics Industry 10World Iris Biometrics Industry 11World Face and Voice Biometrics Industry 2World Face and Voice Biometrics Industry 3World Face and Voice Biometrics Industry 4World Face and Voice Biometrics Industry 5World Face and Voice Biometrics Industry 6World Face and Voice Biometrics Industry 7World Face and Voice Biometrics Industry 8World Face and Voice Biometrics Industry 9World Face and Voice Biometrics Industry 10World Face and Voice Biometrics Industry 11World Face and Voice Biometrics Industry 12World Face and Voice Biometrics Industry 13World Face and Voice Biometrics Industry 14World Face and Voice Biometrics Industry 15World Face and Voice Biometrics Industry 16
... and how scientists should inform participants in genomic studies ... aim of new research funded with a $5.7 million ... and director of the Center for Biomedical Ethics and ... "These new research projects will help us understand how ...
... corals and appear healthy may, in fact, be heading toward ... Society and other groups. Using data from coral ... of researchers identified how overfishing creates a series of at ... collapse. This information can help managers gauge the health of ...
... Institute at St. Joseph,s Hospital and Medical Center have identified ... that represents potential targets of brain injuries affecting newborns. The ... evolves, is published in the current issue of Nature ... Nader Sanai, MD, director of Barrow,s Brain Tumor Research ...
Cached Biology News:Vanderbilt ethicist to study return of results issue involving children in genomics studies 2Wildlife Conservation Society study uncovers a predictable sequence toward coral reef collapse 2Wildlife Conservation Society study uncovers a predictable sequence toward coral reef collapse 3Barrow scientists identify new stem cell activity in human brain 2
... starter kit is intended for first-time users of ... The kit includes a protein sample and reagents ... gels six 17 cm, ten 11 cm, or ... strips and precast SDS-PAGE gels and gels stains ...
... Immunogen : Fusion protein corresponding ... of human Mi-2 Formulation: 0.7M ... 0.035% sodium azide, containing 30% ... by immunoblot on Hela nuclear ...
Anti-CaM kinase II recognizes the enzymes a subunit (6) and reacts with tissue from all mammalian species tested, as well as with chicken and frog tissues....
... to Synaptogyrin 2 ( Abpromise ... Antigen: ... Internal sequence amino acids 42-57 ... Entrez Gene ID: ...
Biology Products: